HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Targeting the endocannabinoid system in the amygdala kindling model of temporal lobe epilepsy in mice.

Abstract
The endocannabinoid system can be considered as a putative target to affect ictogenesis as well as the generation of a hyperexcitable epileptic network. Therefore, we evaluated the effect of a CB1 receptor agonist (WIN55.212-2) and of an inhibitor of the enzymatic degradation of the endocannabinoid anandamide (fatty acid hydrolase inhibitor URB597) in the amygdala kindling model of temporal lobe epilepsy. Only minor effects on seizure thresholds and seizure parameters without a clear dose-dependency were observed in fully kindled mice. When evaluating the impact on kindling acquisition, WIN55.212-2 significantly delayed the progression of seizure severity. In contrast, URB597 did not affect the development of seizures in the kindling paradigm. Analysis of cell proliferation and neurogenesis during the kindling process revealed that URB597 significantly reduced the number of newborn neurons. These data give first evidence that CB1-receptor activation might render a disease-modifying approach. Future studies are necessary that further analyze the role of CB1 receptors and to confirm the efficacy of CB1-receptor agonists in other models of chronic epilepsy.
AuthorsHannes Wendt, Jonna Soerensen, Carsten T Wotjak, Heidrun Potschka
JournalEpilepsia (Epilepsia) Vol. 52 Issue 7 Pg. e62-5 (Jul 2011) ISSN: 1528-1167 [Electronic] United States
PMID21627644 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightWiley Periodicals, Inc. © 2011 International League Against Epilepsy.
Chemical References
  • Benzamides
  • Benzoxazines
  • Carbamates
  • Morpholines
  • Naphthalenes
  • Receptor, Cannabinoid, CB1
  • cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester
  • (3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone
  • Amidohydrolases
  • fatty-acid amide hydrolase
Topics
  • Amidohydrolases (antagonists & inhibitors)
  • Amygdala (drug effects, physiopathology)
  • Animals
  • Benzamides (pharmacology)
  • Benzoxazines (pharmacology)
  • Carbamates (pharmacology)
  • Disease Models, Animal
  • Epilepsy, Temporal Lobe (etiology, physiopathology)
  • Kindling, Neurologic (drug effects, physiology)
  • Male
  • Mice
  • Models, Neurological
  • Morpholines (pharmacology)
  • Naphthalenes (pharmacology)
  • Receptor, Cannabinoid, CB1 (agonists)
  • Seizures (chemically induced, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: